Advertisement

Topics

Antares Company Profile

10:35 EST 18th November 2017 | BioPortfolio

With over a decade of experience developing and building high-end I/O peripherals for Sun® and Intel based systems, the Antares Microsystems’ family of products provide versatile and flexible solutions that are easy to implement in your enterprise.

Location

1624 Dell Avenue
Campbell
CA
95008
United States of America

Contact

Phone: 408 869 7500
Fax: 408 869 7522
Email: sales@antares.com


News Articles [43 Associated News Articles listed on BioPortfolio]

ANTARES LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Antares Pharma, Inc. To Contact The Firm

NEW YORK, NY / ACCESSWIRE / November 15, 2017 / Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Antares Pharma, Inc. ("Antares" or the "Company") (NASDAQ: ATRS) o...

Antares Pharma Implodes After FDA Responds to Its Xyosted NDA

Antares Pharma Provides XYOSTED Regulatory Update EWING, N.J., Oct. 12, 2017 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ:ATRS) today announced that, on October 11, 2017, the Company received a ...

Antares Pharma Announces Sale of ZOMAJET??? Needle-Free Delivery System To Ferring Pharma

EWING, N.J., Oct. 10, 2017 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ:ATRS) (Antares or the Company) today announced that it has entered into a definitive asset purchase agreement to sell the...

Pomerantz LLP: SHAREHOLDER ALERT: Pomerantz Law Reminds Shareholders with Losses on their Investment in Antares Pharma, Inc. of Class Action Lawsuit and Upcoming Deadline - ATRS

NEW YORK, NY / ACCESSWIRE / November 1, 2017 / Pomerantz LLP announces that a class action lawsuit has been filed against Antares Pharma, Inc. ("Antares" or the "Company") (NASDAQ: ATRS) and certai...

Antares Pharma: Will October Deliver A Triple Play?

Xyosted, the testosterone replacement therapy, could result in the company being acquired much sooner than many investors expect if approved October 20. Antares Pharma's stock has rocketed in the ...

Antares Pharma Stock Plunges More Than 30% After FDA Letter

EWING, N.J., Oct. 12, 2017 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ:ATRS) today announced that, on October 11, 2017, the Company received a letter from the U.S. Food and Drug Administration...

European Commission awards Antares Vision a grant for new technology

The European Commission (EC) has awarded Antares Vision, provider of serialisation-based track and trace solutions for the pharma industry, a grant for the development of new technology for the inspec...

EC Awards Antares Grant to Develop Lyophilized Injectables Inspection Technology

NewsAntares Vision awarded European Commission grant to develop new technology for inspection of lyophilized injectables. The Lyo-Check project will result in development of a fully automated industri...

Drugs and Medications [0 Results]

None

PubMed Articles [2 Associated PubMed Articles listed on BioPortfolio]

Sperm whale long-range echolocation sounds revealed by ANTARES, a deep-sea neutrino telescope.

Despite dedicated research has been carried out to adequately map the distribution of the sperm whale in the Mediterranean Sea, unlike other regions of the world, the species population status is stil...

Red-shifted luciferase-luciferin pairs for enhanced bioluminescence imaging.

Red-shifted bioluminescence reporters are desirable for biological imaging. We describe the development of red-shifted luciferins based on synthetic coelenterazine analogs and corresponding mutants of...

Clinical Trials [0 Results]

None

Companies [6 Associated Companies listed on BioPortfolio]

Antares

With over a decade of experience developing and building high-end I/O peripherals for Sun® and Intel based systems, the Antares Microsystems’ family of products provide versatile and flexible solut...

ANTARES PHARMA INC.

The Antares Pharma, Inc. website contains information about products and technologies that may or may not be available in any particular country. Information on the website is not to be construed as a...

Antares Pharma, Inc.

Antares Pharma focuses on self-injection delivery technologies and topical gel-based pharmaceutical products. The Company's subcutaneous and intramuscular injection technology pla...

Antares Pharma, Inc. and Population Council

Antares Pharma focuses on self-injection delivery technologies and topical gel-based pharmaceutical products. The Company’s subcutaneous injection technology platforms includ...

Antares Management Solutions

Antares Management Solutions is a market leader in providing Business Process Outsourcing (BPO) and Information Technology Outsourcing (ITO) services to insurance and other industries. The company's...

More Information about "Antares" on BioPortfolio

We have published hundreds of Antares news stories on BioPortfolio along with dozens of Antares Clinical Trials and PubMed Articles about Antares for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Antares Companies in our database. You can also find out about relevant Antares Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record